The global pharmaceutical industry is witnessing significant growth in vitamin-based therapeutics, driven by the increasing prevalence of neurological disorders, vitamin deficiencies, and chronic diseases. Mecobalamin-based medications have gained substantial attention due to their effectiveness in treating peripheral neuropathy, diabetic neuropathy, and vitamin B12 deficiency. Rising...
Italiano 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt